Hi @hotcongo
Yes, there is something nasty which is often referred as evergreening. But perhaps all is not as bad as you think. Let's look at this hypothetical scenario:
1) Amgen currently sells Carfilzomib for 300K per treatment (before patent expiry). Amgen makes a 15% gross profit, or 45K per treatment
2) In 2025, patent expires and RAC agrees to licence Zantrene combo to Amgen. Amgen now sells Zan+Carfilzomib combo for 320K per treatment. Amgen makes a 15% gross profit, or 48K. Of which, only 3K attributable to Carfilzomib, and 45K from Zantrene (keep in mind, Amgen paid big $$$ for Zantrene).
The alternative is that if a combo did not become SoC, then any competitor would have sold a generic version of Carfilzomib for just 20K with a 15% gross profit, which is 3K. In fact, insurers are unlikely to accept paying more than before for the Carfilzomib side of the combo.What Amgen really gains from this combo, besides added revenue from Zantrene, is that it maintains its leading market share for Carfilzomib.
Other competitors are free to bid for a Zantrene combo! And I am sure patients who can't afford the combo can always by the generic.
- Forums
- ASX - By Stock
- RAC
- Ann: Expanded Heart Protection Discovery for Zantrene
Ann: Expanded Heart Protection Discovery for Zantrene, page-171
-
- There are more pages in this discussion • 216 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.94 |
Change
0.055(2.92%) |
Mkt cap ! $330.4M |
Open | High | Low | Value | Volume |
$1.89 | $1.96 | $1.85 | $333.0K | 174.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3105 | $1.94 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.95 | 7574 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3105 | 1.940 |
2 | 30000 | 1.900 |
1 | 4861 | 1.880 |
1 | 3000 | 1.850 |
1 | 30000 | 1.840 |
Price($) | Vol. | No. |
---|---|---|
1.950 | 7574 | 1 |
1.995 | 10037 | 1 |
2.000 | 8000 | 3 |
2.020 | 4000 | 1 |
2.040 | 2000 | 1 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |